On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

420 with CNW — Cannabis and Fibromyalgia: What Does Available Research Say?

Despite its controversial reputation, cannabis has been slowly but surely building a reputation as a potent and versatile alternative to pharmaceuticals. While most experts agree the hype around cannabis has far outpaced the science, preliminary studies and anecdotal evidence have found it to be effective against everything from stress and anxiety to chronic pain and seizures. In the recent past, there has been increasing evidence that cannabis can help reduce the effects of fibromyalgia.

Fibromyalgia is a chronic condition characterized by widespread, frequent and intense musculoskeletal pain. According to the Centers for Disease Control and Prevention (CDC), roughly 4 million adults in the United States suffer from fibromyalgia. On top of chronic musculoskeletal pain, people with fibromyalgia also experience headaches and migraines, memory and concentration issues, depression and anxiety. In some cases, they may also suffer from lethargy, sleep disturbances, and fatigue as well as emotional or mental distress.

Fibromyalgia is an exacting condition that can greatly diminish the quality of daily life. While there are pharmaceuticals available to treat fibromyalgia, more people have been turning to cannabis as alternative medicine. Research has found that thanks to their analgesic and anti-inflammatory properties, cannabinoids can help alleviate some of the symptoms of fibromyalgia, such as pain. Cannabinoids are chemical compounds produced by the cannabis plant, and they include THC and cannabidiol (CBD).

A randomized, double-blind, placebo-controlled trial done in 2020 sought to better understand how high-THC cannabis oil could be used to treat fibromyalgia symptoms and improve patients’ quality of life. Researchers gave 17 women with fibromyalgia 1.22 mg of THC and 0.02 mg of CBD every day with subsequent increases in dosage based on their symptoms. Additionally, the participants answered a Fibromyalgia Impact Questionnaire before and after they received the cannabis oil and during five visits over the course of eight weeks.

The researchers concluded that cannabinoids such as THC and CBD can be a low-cost, easy-on-the-body therapy for women with fibromyalgia to alleviate symptoms and improve quality of life. However, they noted that more studies will have to be done to determine long-term benefits of using cannabis to reduce fibromyalgia symptoms as well as how different cannabis varieties will affect treatment.

For these treatments to be effective, cannabinoids interact with the endocannabinoid system (ECS), a complex cell-signaling system that regulates functions such as mood, sleep, appetite, and memory. These functions contribute to the body’s homeostasis or internal balance. The researchers who conducted the 2020 study stated that conditions such as fibromyalgia, IBS and migraines, which are characterized by chronic pain, may be partly attributed to the “deregulation” of the ECS.

By interacting with the ECS, cannabinoids such as THC and CBD can give the system a little boost, allowing it to do its job of maintaining internal balance more effectively.

Still on the subject of using cannabis compounds as a medicine, RYAH Group Inc. is set to revolutionize how cannabis medicines are developed and administered. For example, the company has a precise dose-measuring IoT solution that makes it possible for clinical trial teams to be as exact as possible during candidate drug trials involving human subjects.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Archives

Select A Month

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo USA CBD Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722